share_log

Biote Q1 2024 GAAP EPS $(0.06) Misses $0.03 Estimate, Sales $46.804M Beat $45.711M Estimate

バイオテQ1 2024 GAAP EPS (-0.06)は$0.03の見積もりに届かず、売上高は$46.804Mで$45.711Mの見積もりを超えました

Benzinga ·  05/07 17:48

Biote (NASDAQ:BTMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.03 by 300 percent. This is a 84.62 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $46.804 million which beat the analyst consensus estimate of $45.711 million by 2.39 percent. This is a 4.37 percent increase over sales of $44.843 million the same period last year.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする